Methylprednisolone Equivalent Dose
The methylprednisolone (Solumedrol) equivalent of prednisone 30 mg is 24 mg.
Dose Conversion Rationale
The standard glucocorticoid equivalency ratio between prednisone and methylprednisolone is approximately 1.25:1, meaning prednisone is slightly less potent than methylprednisolone on a milligram-per-milligram basis. Using this conversion:
- Prednisone 30 mg = Methylprednisolone 24 mg
This conversion is supported by established glucocorticoid equivalency tables used in clinical practice 1. The 2024 European Society of Endocrinology guideline defines physiologic dose equivalents as 4-6 mg prednisone being equivalent to 3-5 mg methylprednisolone, which maintains this approximate 1.25:1 ratio 1.
Important Clinical Considerations
Route-Specific Factors
When converting between oral prednisone and IV methylprednisolone (Solumedrol), the bioavailability is essentially equivalent at these doses. Research demonstrates that 1250 mg oral prednisone produces similar area under the curve (AUC) to 1000 mg IV methylprednisolone, suggesting comparable absorption 2. This means you can use the standard conversion ratio without adjusting for route of administration.
Potency Differences by Effect Type
Critical caveat: The relative potencies differ depending on whether you're considering genomic (classical anti-inflammatory) versus non-genomic effects. For genomic effects (the typical therapeutic target), methylprednisolone is approximately 1.25 times more potent than prednisone. However, for non-genomic effects, the hierarchy changes significantly 3. In clinical practice, the standard genomic potency ratio is what guides dosing decisions.
Administration Guidelines for IV Methylprednisolone
If administering Solumedrol IV 4:
- Standard doses (24 mg): Can be given by IV push over several minutes
- High doses (>500 mg): Should be administered over at least 30 minutes to avoid cardiac arrhythmias
- The FDA label specifically warns against rapid administration of doses >0.5 grams over <10 minutes due to risk of cardiac arrest
Duration and Tapering Context
The conversion assumes equivalent single-dose potency. However, if this is part of a longer treatment course, remember that 1:
- Supraphysiologic doses (>5 mg prednisone equivalent daily) for >3-4 weeks carry risk of adrenal suppression
- When tapering from either agent, the endocrine taper phase begins once you reach physiologic replacement doses
Practical Application
For a patient currently on prednisone 30 mg oral daily who needs conversion to IV methylprednisolone:
- Give methylprednisolone 24 mg IV daily (can be divided into doses every 6-12 hours if needed)
- This maintains equivalent anti-inflammatory effect
- Monitor for the same therapeutic endpoints you were targeting with oral prednisone